Table 3.
Toxicities by grade and causality in the newly diagnosed GBM patients treated with combined TTFields-Temozolomide.
| Grade | Causality assessment | ||
| I-II | III-IV | ||
| Elevated LFTs | 6/10 | 0/10 | Anti Epileptic Drugs |
| Hyperglycemia | 4/10 | 0/10 | Oral Steroids |
| Anemia | 6/10 | 0/10 | Temozolomide |
| Thrombocytopenia | 2/10 | 0/10 | Temozolomide |
| Leucopenia | 3/10 | 0/10 | Temozolomide |
| Headache | 2/10 | 0/10 | Underlying disease |
| Seizures | 1/10 | 0/10 | Underlying disease |
| Dermatitis | 10/10 | 0/10 | NovoTTF-100A |